Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03226938 · ClinicalTrials.gov registry record
Adhering to Dietary Approaches for Personal Taste (ADAPT)
A clinical trial, sponsored by Tufts University.
- Completed
- Registry status
- 3,001
- Enrollment target
NCT03226938: Completed study, sponsored by Tufts University.
NCT03226938 is a clinical trial that has completed, run by Tufts University. The registered enrollment target is 3,001 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03226938 has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- 3,001 participants
- Enrollment target
Study Summary
Understanding the impact of dietary patterns, exercise, and behavior change in the prevention of disease is paramount to improving the health and well-being of future generations and economies. A gap in the research is the lack of data on factors that predict successful behavior change for sustained dietary practices chosen for health or other personal reasons. To date, no survey exists that was designed to target persons following a wide range of popular dietary patterns (e.g., Paleo, low-carb, vegetarian, vegan, Mediterranean, gluten-free, etc.). These dietary patterns, which offer great variation in macronutrient composition, are unique and unexplored in other similar surveys to date, making their examination innovative. Adhering to Dietary Approaches for Personal Taste (ADAPT) will be the first large cohort of its type that is focused on adherence to popular dietary patterns, providing the opportunity to better understand how individuals can be supported to successfully maintain a specific dietary practice, and, in the long-term, how these practices may influence parameters of healthy aging.
Primary Outcome
Compare actual intake calculated from participant-reported diet history questionnaires and/or diet recalls to targeted nutrient composition of the respective dietary pattern reported by the participant. Targeted nutrient composition will be calculated using 7-day meal plans from popular dietary patterns of interest. These 7-day meal plans will be generated from sources of nutrition information identified by participants in the ADAPT Feasibility Survey which was conducted in the summer of 2015 to
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,001 participants |
| Start Date | 2017-07-24 |
| Est. Completion | 2022-02-11 |
What the finished NCT03226938 record still lists
NCT03226938 is an observational study that tracks outcomes without assigning an intervention. Its 3,001 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03226938 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03226938 about?
NCT03226938 is a clinical study titled "Adhering to Dietary Approaches for Personal Taste (ADAPT)". Understanding the impact of dietary patterns, exercise, and behavior change in the prevention of disease is paramount to improving the health and well-being of future generations and economies. A gap in the research is the lack of data on factors that predict successful behavior change for sustained...
What is the current status of trial NCT03226938?
This trial is currently completed. The enrollment target is 3,001 participants. The study started on 2017-07-24. Estimated completion is 2022-02-11.
Who is sponsoring clinical trial NCT03226938?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI